ArticleBioengineering (Basel, Switzerland)2025
Weakly Supervised Nuclei Segmentation with Point-Guided Attention and Self-Supervised Pseudo-Labeling.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Due to the labor-intensive manual annotations for nuclei segmentation, point-supervised segmentation based on nuclei coordinate supervision has gained recognition in recent years. Despite great progress, two challenges hinder the performance of weakly supervised nuclei segmentation methods: (1) The stable and effective segmentation of adjacent cell nuclei remains an unresolved challenge. (2) Existing approaches rely solely on initial pseudo-labels generated from point annotations for training, and inaccurate labels may lead the model to assimilate a considerable amount of noise information, thereby diminishing performance. To address these issues, we propose a method based on center-point prediction and pseudo-label updating for precise nuclei segmentation. First, we devise a Gaussian kernel mechanism that employs multi-scale Gaussian masks for multi-branch center-point prediction. The generated center points are utilized by the segmentation module to facilitate the effective separation of adjacent nuclei. Next, we introduce a point-guided attention mechanism that concentrates the segmentation module's attention around authentic point labels, reducing the noise impact caused by pseudo-labels. Finally, a label updating mechanism based on the exponential moving average (EMA) and k-means clustering is introduced to enhance the quality of pseudo-labels. The experimental results on three public datasets demonstrate that our approach has achieved state-of-the-art performance across multiple metrics. This method can significantly reduce annotation costs and reliance on clinical experts, facilitating large-scale dataset training and promoting the adoption of automated analysis in clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.